Goodness Growth appoints Josh Rosen as Interim President with $300K salary, 2M options

Vireo Growth Inc.

Josh Rosen appointed Interim President of Goodness Growth and Vireo Health, effective Dec 5, 2022.
Base compensation $300K/year (40% deferred); option to purchase 2M subordinate voting shares, 500K vested immediately.
C-suite to report to Rosen; Dr. Kingsley remains CEO focusing on strategy, government relations, and medical cannabis.
Rosen previously a board member since Aug 2021; also Managing Partner of Bengal Capital and former CEO of 4Front Ventures.
Appointment follows termination of planned merger with Verano; Rosen to focus on operational efficiencies and adult-use markets.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Joshua Rosen

Interim President

VREOF · Vireo Growth Inc.

Effective: 2022-12-05
Filed: December 8, 2022, 6:59 PM ET

On December 5, 2022, the Parent Company announced the appointment of Joshua Rosen, age 49, as Interim President of the Parent Company and the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joshua Rosen was appointed as Interim President at Vireo Growth Inc..

Action: appointed
Role: Interim President

Exact text from the filing

On December 5, 2022, the Parent Company announced the appointment of Joshua Rosen, age 49, as Interim President of the Parent Company and the Company.

View on SEC.gov

Vireo Growth Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-125534

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.